Relmada Therapeutics, Inc. (RLMD)
2.65
-0.46
(-14.79%)
USD |
NASDAQ |
Nov 20, 15:51
Relmada Therapeutics Price to Book Value : 1.459 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.713 |
| November 18, 2026 | 1.572 |
| November 17, 2026 | 1.658 |
| November 16, 2026 | 1.988 |
| November 13, 2026 | 2.318 |
| November 12, 2026 | 2.291 |
| November 11, 2026 | 2.440 |
| November 10, 2026 | 2.352 |
| November 09, 2026 | 2.28 |
| November 06, 2026 | 2.148 |
| November 05, 2026 | 2.076 |
| November 04, 2026 | 2.296 |
| November 03, 2026 | 2.352 |
| November 02, 2026 | 2.115 |
| October 30, 2026 | 1.972 |
| October 29, 2026 | 1.894 |
| October 28, 2026 | 1.845 |
| October 27, 2026 | 1.768 |
| October 26, 2026 | 1.779 |
| October 23, 2026 | 1.801 |
| October 22, 2026 | 1.812 |
| October 21, 2026 | 1.768 |
| October 20, 2026 | 1.850 |
| October 19, 2026 | 1.740 |
| October 16, 2026 | 1.707 |
| Date | Value |
|---|---|
| October 15, 2026 | 1.762 |
| October 14, 2026 | 1.784 |
| October 13, 2026 | 1.850 |
| October 12, 2026 | 1.933 |
| October 09, 2026 | 1.867 |
| October 08, 2026 | 1.746 |
| October 07, 2026 | 1.790 |
| October 06, 2026 | 1.806 |
| October 05, 2026 | 1.916 |
| October 02, 2026 | 1.983 |
| October 01, 2026 | 2.016 |
| September 30, 2026 | 2.076 |
| September 29, 2026 | 1.926 |
| September 28, 2026 | 1.957 |
| September 25, 2026 | 1.978 |
| September 24, 2026 | 1.968 |
| September 23, 2026 | 1.952 |
| September 22, 2026 | 2.190 |
| September 21, 2026 | 2.148 |
| September 18, 2026 | 2.128 |
| September 17, 2026 | 2.169 |
| September 16, 2026 | 2.179 |
| September 15, 2026 | 2.293 |
| September 14, 2026 | 2.293 |
| September 11, 2026 | 2.334 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Talphera, Inc. | 3.928 |
| Journey Medical Corp. | 2.888 |
| ANI Pharmaceuticals, Inc. | 2.474 |
| Corcept Therapeutics, Inc. | 8.302 |
| Veru, Inc. | 1.172 |
Price to Book Value Related Metrics
| Price | 2.65 |
| Earnings Yield | -28.28% |
| Market Cap | 282.74M |